ArticleJournal of bone metabolism2017

Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways.

Ting Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.